Endocrine Today Current Issue

The following articles appeared in the print edition of Endocrine Today.

Table of Contents

• Maintenance of certification under fire by endocrinologists
• Prediabetes criteria could be costly for patients, health care system
• Reward-based learning impaired for women with obesity when it comes to food
• Sweet ups and downs: Investigating the cause of recurrent severe hyperglycemia in a hospitalized patient Ronald Tamler, MD, PhD, MBA
• Achievement of target LDL particle number leads to fewer CV events James A. Underberg, MS, MD, FACP, FACPM, FNLA
• FDA opens dialogue on interim results of CV safety in diabetes drug trials
• FDA to review empagliflozin/linagliptin tablet for treating type 2 diabetes
• Comet tail, cat eye and colloid clot artifact found in thyroid nodules Stephanie L. Lee, MD, PhD, ECNU
• Addition of insulin to metformin increased mortality risk in diabetes
• Diabetes increased polytrauma complications risk, including death
• Early initiation of menopausal hormone therapy did not affect atherosclerosis progression
• Estradiol drop could explain blood hemoglobin decreases in older men
• Gestational diabetes risk increased with hormonal contraception use
• High burden of hypoparathyroidism revealed in Web-based patient survey
• High steroid levels in utero resulted in autism spectrum disorders
• Higher dose radioactive iodine improved response to therapy in older PTC patients
• Low vitamin D increased risk for schizophrenia diagnosis
• Metformin appears to control blood glucose better in black patients
• Oxidative stress predicted future hip fracture for postmenopausal women
• PTH therapy improved long-term health of hypoparathyroid patients
• Rare gene variant linked to type 2 diabetes in Latino population
• SSRI escitalopram did not affect bone metabolism in middle-aged women
• Thyroid disease diagnosis leads to work absence, disability in first year
• Axitinib active in advanced thyroid cancer
• USPSTF: Not enough evidence to warrant vitamin D screenings
• Control solution needs to be better understood by patients, pharmacists, providers
• Diabetes education effective in low-income, high-immigrant community
• FREEDOM, ADAMO: Denosumab improved BMD in women and men
• Teens cautious using social media for diabetes support, but want to help others
• Telehealth delivery of diabetes education extends staff, personalizes care